Literature DB >> 30178831

Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease.

Y Zhou1, S Wang, J Zhao, P Fang.   

Abstract

OBJECTIVE: To investigate the correlations of complication with coronary arterial lesion (CAL) or not with vascular endothelial growth factor (VEGF), platelet (PLT), D-dimer, and inflammatory factor in child patients with Kawasaki disease (KD). PATIENTS AND METHODS: A total of 60 KD child patients meeting the inclusion criteria diagnosed and treated from January 2016 to October 2017 were collected. There were 27 child patients complicated with CAL enrolled as observation group and 33 child patients not complicated with CAL selected as control group. The venous blood of the two groups of patients was acquired after admission to hospital. Enzyme-linked immunosorbent assay (ELISA) was utilized to detect the content of serum VEGF and interleukin-6 (IL-6); the content of serum PLT and D-dimer was measured using a fully automatic biochemistry analyzer, and the coronary artery diameter was determined through color Doppler ultrasound.
RESULTS: Compared with those in control group, the content of VEGF, IL-6, PLT, and D-dimer in the serum was increased remarkably in the observation group, and the differences were statistically significant (p<0.05). The thickness of the coronary artery in the observation group was markedly greater than that in the control group, with a statistically significant difference (p<0.05). The content of VEGF, IL-6, PLT, and D-dimer in the serum was positively correlated with the thickness of the coronary artery.
CONCLUSIONS: For KD child patients, the complication with CAL or not has a close correlation with VEGF, PLT, D-dimer, and inflammatory factor; and VEGF, IL-6, PLT, and D-dimer are the important risk factors for KD complicated with CAL.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30178831     DOI: 10.26355/eurrev_201808_15706

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

Review 1.  Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.

Authors:  Qing-You Zhang; Bo-Wen Xu; Jun-Bao Du
Journal:  World J Pediatr       Date:  2021-05-20       Impact factor: 2.764

2.  Combined IFN-β and PLT Detection Can Identify Kawasaki Disease Efficiently.

Authors:  Kan Huijuan; Dong Yaping; Wang Bo; Hou Miao; Qian Guanghui; Yan Wenhua
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

3.  Overexpressed Neuropilin-1 in Endothelial Cells Promotes Endothelial Permeability through Interaction with ANGPTL4 and VEGF in Kawasaki Disease.

Authors:  Junhua Huang; Shuwan Zhang
Journal:  Mediators Inflamm       Date:  2021-08-13       Impact factor: 4.711

4.  Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.

Authors:  Man Man Niu; Qi Jiang; Jin Wei Ruan; Hui Hui Liu; Wei Xia Chen; Zhen Qiu; Guo Zhen Fan; Rui Xue Li; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2021-04-11       Impact factor: 3.984

5.  Efficacy evaluation and mechanical study of short- and long-term antithrombotic therapy for Kawasaki disease.

Authors:  Jingxia Hao; Hua Wang; Jingshi Chen; Bo Li; Huimin Zhang; Yingqian Zhang
Journal:  Transl Pediatr       Date:  2021-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.